Instil Bio Statistics

Total Valuation

Instil Bio has a market cap or net worth of $76.68 million. The enterprise value is $7.02 million.

Market Cap	76.68M
Enterprise Value	7.02M

Important Dates

The last earnings date was Friday, May 10, 2024, before market open.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

Instil Bio has 6.50 million shares outstanding.

Shares Outstanding	6.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	66.25%
Float	3.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.19, with a Debt / Equity ratio of 0.41.

Current Ratio	14.19
Quick Ratio	n/a
Debt / Equity	0.41
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-17.82

Financial Efficiency

Return on equity (ROE) is -51.30% and return on invested capital (ROIC) is -43.00%.

Return on Equity (ROE)	-51.30%
Return on Assets (ROA)	-35.70%
Return on Capital (ROIC)	-43.00%
Revenue Per Employee	n/a
Profits Per Employee	-$2.52M
Employee Count	49
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -4.36% in the last 52 weeks. The beta is 1.18, so Instil Bio's price volatility has been higher than the market average.

Beta (1Y)	1.18
52-Week Price Change	-4.36%
50-Day Moving Average	11.24
200-Day Moving Average	9.45
Relative Strength Index (RSI)	54.04
Average Volume (30 Days)	13,351

Short Selling Information

The latest short interest is 7,447, so 0.11% of the outstanding shares have been sold short.

Short Interest	7,447
Short Previous Month	9,299
Short % of Shares Out	0.11%
Short % of Float	0.24%
Short Ratio (days to cover)	0.72

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-124.68M
Pretax Income	-123.32M
Net Income	-123.32M
EBITDA	-112.47M
EBIT	-116.77M
Earnings Per Share (EPS)	-$18.94

Full Income Statement

Balance Sheet

The company has $153.79 million in cash and $84.13 million in debt, giving a net cash position of $69.66 million or $10.71 per share.

Cash & Cash Equivalents	153.79M
Total Debt	84.13M
Net Cash	69.66M
Net Cash Per Share	$10.71
Equity / Book Value	205.83M
Book Value Per Share	31.65
Working Capital	149.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.76 million and capital expenditures -$12.20 million, giving a free cash flow of -$73.96 million.

Operating Cash Flow	-61.76M
Capital Expenditures	-12.20M
Free Cash Flow	-73.96M
FCF Per Share	-$11.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Instil Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-160.82%
FCF Yield	-96.44%

Analyst Forecast

The average price target for Instil Bio is $20.33, which is 76.78% higher than the current price. The consensus rating is "Buy".

Price Target	$20.33
Price Target Difference	76.78%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	2